Market Cap : 60.55 B | Enterprise Value : 58.31 B | PE Ratio : 39.90 | PB Ratio : 10.37 |
---|
NYSE:EW has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
NYSE:EW has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
Edwards Lifesciences has the Profitability Rank of 10. It has a higher profitability and may stay that way.
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company's business will stay that way. It is based on these factors:
1. Operating Margin %Edwards Lifesciences's Operating Margin % for the quarter that ended in Mar. 2022 was 33.03%. As of today, Edwards Lifesciences's Piotroski F-Score is 8.
For the Medical Devices subindustry, Edwards Lifesciences's Profitability Rank, along with its competitors' market caps and Profitability Rank data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
For the Medical Devices & Instruments industry and Healthcare sector, Edwards Lifesciences's Profitability Rank distribution charts can be found below:
* The bar in red indicates where Edwards Lifesciences's Profitability Rank falls into.
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company's business will stay that way.
The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.
Edwards Lifesciences has the Profitability Rank of 10. It has a higher profitability and may stay that way.
Profitability Rank is not directly related to the Financial Strength. But if a company is consistently profitable, its financial strength will be stronger.
Profitability Rank is based on these factors:
Operating Margin % - also known as operating income margin, operating profit margin and return on sales (ROS) - is the ratio of Operating Income divided by net sales or Revenue, usually presented in percent.
Edwards Lifesciences's Operating Margin % for the quarter that ended in Mar. 2022 is calculated as:
Operating Margin % | = | Operating Income (Q: Mar. 2022 ) | / | Revenue (Q: Mar. 2022 ) |
= | 443 | / | 1341.2 | |
= | 33.03 % |
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Good Sign:
Piotroski F-Score is 8, indicating very healthy situation.
The zones of discrimination were as such:
Good or high score = 8 or 9
Bad or low score = 0 or 1
Edwards Lifesciences has an F-score of 8. It is a good or high score, which usually indicates a very healthy situation.
3. Trend of the Operating Margin % (5-year average). The company with an uptrend profit margin has a higher rank.
Good Sign:
Edwards Lifesciences Corp operating margin is expanding. Margin expansion is usually a good sign.
4. Consistency of the profitability
5. Predictability Rank
Thank you for viewing the detailed overview of Edwards Lifesciences's Profitability Rank provided by GuruFocus.com. Please click on the following links to see related term pages.
Ullem Scott B. | officer: CVP, Chief Financial Officer | C/O EDWARDS LIFESCIENCES CORPORATION ONE EDWARDS WAY IRVINE CA 92614 |
Bobo Donald E Jr | officer: CVP,Strategy/Corp Development | C/O EDWARDS LIFESCIENCES ONE EDWARDS WAY IRVINE CA 92614 |
Mussallem Michael A | director, officer: Chairman & CEO | C/O EDWARDS LIFESCIENCES CORP ONE EDWARDS WAY IRVINE CA 92614 |
Wang Huimin | officer: CVP, Japan & Intercontinental | C/O EDWARDS LIFESCIENCES ONE EDWARDS WAY IRVINE CA 92614 |
Wood Larry L | officer: CVP, TAVR | C/O EDWARDS LIFESCIENCES CORPORATION ONE EDWARDS WAY IRVINE CA 92614 |
Sellers Robert W.a. | officer: VP, Corporate Controller | ONE EDWARDS WAY IRVINE CA 92614 |
Szyman Catherine M. | officer: CVP, Critical Care | C/O EDWARDS LIFESCIENCES CORPORATION ONE EDWARDS WAY IRVINE CA 92614 |
Laviolette Paul A | director | ONE BOSTON PLACE 201 WASHINGTON STREET, SUITE 3900 BOSTON MA 02108 |
Lemercier Jean-luc M | officer: CVP, EMEA, Canada, Latin Amer | C/O ONE EDWARDS WAY IRVINE CA 92614 |
Sequeira Ramona | director | ONE EDWARDS WAY IRVINE CA 92614 |
Marsh Martha H. | director | 9769 WEXFORD CIRCLE GRANITE BAY CA 95746 |
Gallahue Kieran | director | 7530 DRAPER AVENUE SUITE 6 LA JOLLA CA 92037 |
Valeriani Nicholas J | director | C/O EDWARDS LIFESCIENCES CORPORATION ONE EDWARDS WAY IRVINE CA 92614 |
Stone Heisz Leslie | director | C/O PUBLIC STORAGE 701 WESTERN AVENUE GLENDALE CA 91201 |
Link William J Phd | director | ONE SANSOME STREET SUITE 3630 SAN FRANCISCO CA 94104 |
Other Sources
By Zacks 2022-03-14
By Zacks 2022-01-26
By Zacks 2022-04-05
By Zacks 2022-04-05
By Zacks 2022-01-25
By Zacks 2022-01-26
By tipranks.com 2022-03-31
By tipranks.com 2022-02-25
By Zacks 2022-04-05
By Zacks 2022-03-22